Enteric coating is an acid-resistant layer applied to an oral dosage form. It helps protect the product from gastric acid and prevents release in the stomach. After the dosage form reaches a part of the gastrointestinal tract with a suitable pH, the coating begins to dissolve and the active ingredient can be released.
This simple idea serves several purposes. The coating may protect an acid-sensitive drug from the stomach, reduce direct contact between an irritating ingredient and the stomach lining, or deliver an ingredient to the intestine. Enteric coating can be used on tablets, pellets, granules and selected capsules.
However, an enteric-coated product is not simply a normal pill with a thicker outer layer. Its performance depends on polymer chemistry, formulation compatibility, coating uniformity, drying, curing, packaging and dissolution testing. For patients, it also matters how the medicine is taken. Crushing or chewing an enteric-coated tablet can destroy the functional barrier.
Key takeaways:
– Enteric coating resists acidic stomach conditions and releases at a higher pH. – Enteric-coated tablets and capsules are delayed-release dosage forms, but not every delayed-release product uses the same technology. – The coating can protect the active ingredient, the stomach, or the intended site of delivery. – Release does not occur at one guaranteed number of minutes because gastric emptying varies. – Reliable manufacturing requires a suitable polymer, uniform spraying, controlled drying and product-specific quality testing.
What Is Enteric Coating
Enteric coating is a functional film designed to remain intact in the acidic environment of the stomach and become soluble or permeable later in the digestive tract. The word *enteric* relates to the intestine. An enteric-coated tablet, enteric-coated pill or enteric-coated capsule is therefore designed to delay release until after gastric transit.
People use several similar searches: “what is enteric coated,” “what does enteric coated mean,” “enteric coating meaning” and “enteric coated definition.” They all describe the same basic concept: a pH-responsive barrier separates the dosage-form core from gastric fluid for a specified part of its journey.
Enteric Coating Is a Functional Coating
A standard immediate-release film may improve appearance, mask taste, make swallowing easier or offer limited protection from moisture. An enteric film has a performance requirement. It must resist the specified acid stage and then allow release under the specified buffer conditions.
That difference is important. Color, gloss and film thickness alone cannot confirm enteric performance. A smooth enterically coated tablet can still fail if the film contains pores, cracks, thin areas or an unsuitable polymer level.
What Can Be Enteric Coated
Enteric technology is not limited to a single tablet core. Enteric-coated drugs can be supplied as tablets, particles or enteric-coated capsules. Manufacturers may coat:
– Conventional tablets or mini-tablets
– Pellets or granules that are filled into capsules
– Hard capsules, using a validated capsule-coating process
– Selected soft capsules or other specialized oral dosage forms
The [FDA Orange Book Preface] explains that enteric coatings are used to delay release until a dosage form has passed through the stomach. In practice, an intestinal-release profile can be built into tablets, capsules or multiparticulate systems.
How Does Enteric Coating Work
vMost enteric coating systems use polymers with pH-dependent solubility. In the low-pH conditions of the stomach, the polymer remains largely insoluble and forms a barrier around the tablet, capsule or particle. At a higher pH, chemical groups in the polymer ionize, allowing the film to hydrate, swell, dissolve or become permeable.
The exact dissolution threshold depends on the polymer grade and complete formulation. It should not be reduced to one universal statement such as “all enteric coatings dissolve at pH 6.” Different polymers are selected for release in different regions of the intestine.
From Swallowing to Intestinal Release
The process can be understood in four stages:
1. Swallowing: The enteric-coated medication enters the stomach with its protective film intact.
2. Acid resistance: The coating limits fluid penetration and premature drug release during the specified gastric phase.
3. Gastric emptying: The dosage form moves from the stomach into the small intestine. The timing varies with food, physiology and the product.
4. Release: At a suitable intestinal pH, the coating changes and the core begins to disintegrate or release its contents.
Disintegration, dissolution and absorption are related but different. Disintegration is the dosage form breaking apart. Dissolution is the active ingredient entering solution. Absorption is the movement of the active across a biological barrier. Enteric coating changes where and when release begins; it does not by itself guarantee faster or greater absorption.
Why Release Time Is Not Fixed
An enteric pill is often described as “time release,” but that can be misleading. Most conventional enteric systems respond mainly to environmental pH, not to a built-in clock. Gastric emptying time varies, so two doses do not necessarily reach the intestine at exactly the same time.
Food can delay gastric emptying and change gastrointestinal conditions. Polymer threshold, coating thickness, tablet size, core behavior and package storage also affect performance. Our guide to [how long pills take to dissolve] explains why dosage-form breakdown cannot be predicted from appearance alone.
Why Are Medicines Enteric Coated
The purpose of enteric coating depends on the product. “Stomach protection” is only one possible reason, and it should not be assumed for every enteric-coated drug.
Protecting Acid Sensitive Ingredients
Some active ingredients are unstable in acidic gastric fluid. If they are released in the stomach, part of the dose may degrade before reaching the intended absorption site. A properly designed acid-resistant coating can protect the core during gastric transit.
Protection may also be useful for selected enzymes, probiotics and other ingredients whose function can be reduced by acidic conditions. The product still requires evidence that its coating, formulation and storage system provide the intended protection.
Reducing Direct Gastric Exposure
For selected medicines, delayed release can reduce direct contact between the active ingredient and the stomach. This does not mean that an enteric-coated medicine has no gastrointestinal risks or that it is automatically safer for every person. Enteric coating changes the release location; it does not remove the pharmacological effects of the active ingredient.
Consumers should follow the label and professional advice, especially for medicines used long term or combined with other drugs. An enteric coating is a formulation feature, not a substitute for appropriate medical guidance.
Delivering the Ingredient to the Intestine
Some formulations are intended to act locally in the intestine or deliver the active closer to a preferred absorption site. Polymer grades with different pH thresholds can support release in the upper intestine or farther along the gastrointestinal tract.
Targeting is not determined by pH alone. Transit time, local fluid volume, disease state, food and variability between people can influence release. A colon-targeted formulation therefore requires more development than simply selecting a polymer with a high nominal dissolution pH.
Enteric Coated Tablets Capsules and Pellets
The phrase *enteric-coated medication* covers several physical designs. Each design handles manufacturing risk and drug release differently.
Enteric Coated Tablets
An enteric-coated tablet normally starts as a compressed tablet core. The manufacturer may apply a protective subcoat before spraying the enteric layer. A final overcoat may then improve handling, appearance or moisture protection.
Single-unit tablets are straightforward to package and identify, but their entire dose depends on the integrity of one coated unit. Edge damage, cracking or an incomplete film can compromise acid resistance. Tablet hardness, friability and shape must therefore suit the coating process.
Enteric Coated Capsules
The term *enteric coating capsules* can describe more than one design. A hard capsule shell may itself be coated, or a normal capsule may contain enteric-coated pellets, granules or mini-tablets. These designs are not interchangeable.
Coating an assembled capsule introduces challenges such as shell moisture, cap-body movement and adhesion at the joint. Filling a capsule with coated multiparticulates can distribute the dose across many units and offer formulation flexibility, but pellet coating and capsule filling must both be controlled.
Pellets Granules and Multiparticulates
Enteric-coated pellets or granules are small units carrying a functional film. They may be filled into a two-piece capsule or compressed into a multiple-unit pellet system tablet when the particles can withstand compression.
Multiparticulates can spread through the gastrointestinal tract differently from one large tablet. They can also combine particles with different release profiles in one dose. However, the greater total surface area increases coating demand, and damaged particles can cause premature release
| Dosage form | Basic design | Main manufacturing concern |
|---|---|---|
| Enteric-coated tablet | One compressed core with a functional outer film | Complete, uniform coverage without cracks or edge damage |
| Coated hard capsule | Assembled capsule receives an enteric film | Adhesion, shell compatibility and joint coverage |
| Capsule with coated pellets | Prefabricated capsule contains many coated units | Pellet uniformity, fill accuracy and coating damage |
| Multiparticulate tablet | Coated particles are compressed into a tablet | Protecting the particle coating during compression |
Common Enteric Coating Materials
Enteric coating materials are usually weakly acidic polymers. They remain less soluble at low pH and become more soluble as pH rises. Common families include cellulose derivatives, methacrylic acid copolymers and selected natural or specialty materials.
Cellulose Based Polymers
Common cellulose-based enteric polymers include:
– Cellulose acetate phthalate, commonly shortened to CAP
– Hypromellose phthalate, also called HPMCP
– Hypromellose acetate succinate, also called HPMCAS
– Cellulose acetate trimellitate, or CAT
These materials differ in dissolution threshold, film properties, moisture response and compatibility. HPMCAS, for example, is available in grades designed for different release conditions. A formulation scientist selects a grade using the target site and product data, not the polymer name alone.
Methacrylic Acid Copolymers
Methacrylic acid copolymers are widely used for pH-dependent drug delivery. Commercial grades can be selected for release above different pH ranges. They may be supplied as powders, aqueous dispersions or organic solutions, depending on the product and process.
Research on [commonly used enteric polymers](https://pmc.ncbi.nlm.nih.gov/articles/PMC10390825/) lists CAP, HPMCP, HPMCAS, polymethacrylates and polyvinyl acetate phthalate among established options. The same research also shows why the full polymer chemistry matters: dissolution behavior changes with functional groups and formulation conditions.
Shellac and Other Materials
Shellac has a long history in pharmaceutical coating, but its dissolution behavior can change with formulation and storage. Other investigated materials include alginate, pectin, zein and modified natural polymers. A “natural” origin does not automatically provide better performance, easier validation or a cleaner regulatory path.
The polymer must be evaluated as part of the finished dosage form. Aging, moisture and interactions with the core can change film behavior over shelf life.
Plasticizers Pigments and Supporting Layers
The enteric polymer is only one component of the coating formulation. Plasticizers improve flexibility and reduce cracking. Anti-tacking agents help control sticking. Pigments or opacifiers provide color and light protection. Surfactants can support wetting and dispersion.
A seal coat or subcoat may separate the active ingredient from the acidic groups in an enteric polymer. This is especially important when direct contact could affect stability. An overcoat may improve handling and appearance, but it must not block the required release.
| Component | Typical purpose | What must be controlled |
|---|---|---|
| Enteric polymer | Creates the acid-resistant, pH-responsive film | Grade, concentration and target dissolution threshold |
| Plasticizer | Improves flexibility and film formation | Type, ratio and migration during storage |
| Anti-tacking agent | Reduces tablet-to-tablet adhesion | Dispersion and spray suspension uniformity |
| Pigment or opacifier | Adds identification or light protection | Distribution, stability and regulatory suitability |
| Solvent or vehicle | Carries the coating solids to the product | Drying capacity, safety and compatibility |
| Subcoat | Separates or protects the core | Coverage, adhesion and effect on release |
Enteric Coating Manufacturing Process
Industrial enteric coating combines formulation science with heat and mass transfer. A [tablet coating machine]must keep the product moving, distribute the spray and remove solvent at a controlled rate. The goal is a continuous film, not simply a target color.
Preparing the Tablet Core
The core should have sufficient hardness, low friability and a shape that moves evenly in the coating pan. Dust and weak edges can cause roughness, chipping or exposed areas. Before coating starts, the batch, equipment, spray system and environmental conditions should be checked against the approved process.
Tablet quality begins during compression. Consistent fill, compression and ejection help produce cores that can tolerate coating. Manufacturers evaluating this upstream stage can compare suitable [tablet press machines]by tooling, force control and output.
Preparing the Coating Dispersion
The polymer, plasticizer, pigment and other components are added in a controlled sequence. Mixing should create a uniform dispersion without excessive foam, settling or agglomeration. Solids content and viscosity affect atomization, spray rate and drying load.
Aqueous coating systems avoid many hazards associated with organic solvents, but water requires substantial drying energy and may challenge moisture-sensitive cores. Organic solvent systems can dry quickly, yet require appropriate explosion protection, solvent recovery, ventilation and environmental controls. The selection is product- and facility-specific.
Spraying Drying and Film Formation
In a perforated coating pan, the product bed tumbles while spray guns apply droplets. Conditioned process air supplies heat and carries away evaporated solvent. The droplets must wet the surface, spread and coalesce into a continuous film before drying is complete.
If spraying is too fast for the drying capacity, the bed can overwet and tablets may stick or twin. If drying is too aggressive, droplets may dry before spreading, creating roughness or weak adhesion. The correct balance depends on product temperature, inlet and exhaust conditions, air volume, spray rate, atomization pressure, gun position, pan speed and coating formulation.
Curing and Final Handling
Some polymer dispersions need curing after spraying so polymer particles can coalesce and the film can reach stable performance. Time and temperature must be validated because insufficient curing may cause variable release, while excessive heat can affect the drug or core.
Finished products are cooled, sampled and protected from damage. Packaging must control moisture and other environmental risks through the intended shelf life. Depending on product sensitivity, manufacturers may choose bottles, standard blisters or higher-barrier packaging using suitable [blister packing equipment].
Critical Process Parameters
The following parameters should be understood as an interacting system:
– Product temperature: Indicates the thermal condition of the moving bed more directly than inlet temperature alone.
– Spray rate: Must match the available drying capacity and tablet surface area.
– Atomization air: Influences droplet size and distribution.
– Pattern air and gun position: Affect spray coverage and overlap.
– Pan speed: Controls mixing, bed turnover and mechanical stress.
– Airflow and humidity: Influence evaporation and final film properties.
– Coating weight gain: Provides a useful process measure but does not replace functional testing.
There is no universal setting such as one correct inlet temperature or spray rate for all enteric-coated tablets. Equipment scale, batch load, tablet geometry, polymer system and process-air design change the operating window.
Enteric Coated vs Delayed Release
Enteric coated and delayed release are closely related, but they are not perfect synonyms in every context. *Delayed release* describes the result: release begins later than it would from a conventional immediate-release dosage form. *Enteric coating* describes a common way to produce that delay by resisting stomach acid.
The FDA lists “tablet, delayed release” and “capsule, delayed release” as dosage-form terms. Product labeling commonly uses delayed release even when an enteric film creates the performance.
Enteric Coating vs Immediate Release
An immediate-release tablet is not designed with an intentional release delay. It may still carry a normal film coating for taste, color or handling. An enteric-coated tablet must remain protected during its specified acid exposure and release later under appropriate conditions.
Enteric Coating vs Extended Release
Extended release, sustained release and controlled release refer to products designed to release an active over a longer period. Enteric coating usually delays the *start* of release rather than extending the entire release period.
A formulation can combine mechanisms. For example, an enteric barrier may delay access to an inner matrix that then provides extended release. The label and product-specific data—not the appearance of the tablet—tell the user how it is designed.
Enteric Coating vs Standard Film Coating
Both processes may use a coating pan and spray system, but their objectives differ. A standard film coat may improve appearance, identification, swallowing or environmental protection. An enteric coating must deliver verified acid resistance and subsequent release.
This is why substituting one coating formula for another is not a cosmetic change. It can alter drug release, stability, manufacturing conditions and regulatory requirements.
Quality Control and Common Coating Defects
An enteric-coated product must look acceptable and perform correctly. Visual inspection alone cannot establish acid resistance or intestinal release.
Important Quality Tests
Manufacturers may evaluate appearance, average weight, coating weight gain, film thickness, assay, content uniformity, moisture, disintegration, dissolution and stability. The exact specification depends on the product, market and approved method.
[FDA Q6A guidance] discusses two-stage testing for delayed-release dosage forms. For an enteric product, this commonly means an acid stage followed by a buffer stage. These tests answer different questions:
– Acid-stage performance: Does the dosage form remain sufficiently intact under the defined acidic conditions?
– Buffer-stage disintegration or dissolution: Does it release appropriately after conditions change?
– Stability testing: Does the release profile remain acceptable after storage?
A product can pass appearance checks and still fail dissolution. It can also pass at release and drift during aging if the film, plasticizer, core or package changes.
Common Enteric Coating Defects
| Defect | What it looks like | Possible causes | Why it matters |
|---|---|---|---|
| Sticking or picking | Material adheres to another tablet or equipment surface | Overwetting, insufficient drying, tacky formulation | Can create exposed or uneven areas |
| Twinning | Two tablets stick together | Product shape, overwetting or poor bed movement | Prevents uniform spray coverage |
| Chipping or cracking | Film breaks at edges or across the surface | Brittle film, weak cores, mechanical stress | May reduce acid resistance |
| Orange peel or roughness | Textured, non-smooth film | Large droplets, high viscosity or premature drying | Signals poor film spreading and possible nonuniformity |
| Color variation | Uneven shade within the batch | Poor mixing, uneven spray or pigment migration | May indicate nonuniform application |
| Bridging or filling | Film covers logos, scores or embossing | High viscosity, excessive application or poor atomization | Reduces identification and can hide weak areas |
| Premature release | Drug releases during the acid stage | Thin, porous, cracked or under-cured film | Defeats the enteric function |
| Slow buffer release | Product remains resistant after the acid stage | Excess coating, aging, unsuitable polymer or over-curing | Delays availability beyond the intended profile |
Troubleshooting the Process
The fastest adjustment is not always the correct one. A high spray rate, for example, may cause sticking, but the underlying issue could also be low airflow, poor atomization, an incorrect gun-to-bed distance or a coating dispersion outside specification.
A disciplined investigation should compare the defect location, batch timeline, spray records, product temperature, exhaust conditions, weight-gain samples and dissolution results. Change one controlled factor at a time and verify the result. Formulation and equipment settings must be investigated together.
English 
Español de México 
Русский